Wednesday, June 26, 2019

JAK2 and Its Regulators beyond Myeloproliferative Neoplasms-Journal of Tumor Medicine & Prevention-Juniper Publishers

JUNIPER PUBLISHERS-Journal of Tumor Medicine & Prevention


JAK2 and Its Regulators beyond Myeloproliferative Neoplasms


Authored by Nahla A M Hamed*

Dysregulated JAK2 is at the apex of three classic oncogenic signaling cascades including STAT, PI3K/Akt/mTOR, and MAPK pathways. Their interrelationship and dependencies downstream of JAK2 in MPN cells is incompletely understood. Combined pathway inhibition in vitro might prove beneficial due to a synergistic impact on functionally redundant oncogenic axes, might allow lower doses of the different agents with better tolerability, and might avoid or delay the development of resistance.

For Read More... Fulltext click on: https://juniperpublishers.com/jtmp/JTMP.MS.ID.555598.php

For More Articles in Journal of Tumor Medicine & Prevention Please Click on:
https://juniperpublishers.com/jtmp/index.php

For More Open Access Journals In Juniper Publishers Please Click on: 

No comments:

Post a Comment

Juniper Publishers FAQs: Your Guide to Common Publishing Questions and Solutions

  Juniper Publishers FAQ's Q: What are the Manuscript Guidelines in Open Access Journal Publishers? A: Manuscript guidelines in ope...